{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:20:54Z","timestamp":1768782054120,"version":"3.49.0"},"reference-count":60,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2014,10,14]],"date-time":"2014-10-14T00:00:00Z","timestamp":1413244800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100004323","name":"Amylin Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004323","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetes Obesity Metabolism"],"published-print":{"date-parts":[[2015,1]]},"abstract":"<jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>\n                      To test the impact of cholecystokinin (\n                      <jats:styled-content style=\"fixed-case\">CCK<\/jats:styled-content>\n                      ) plus either amylin or a glucagon\u2010like peptide\u20101 receptor (\n                      <jats:styled-content style=\"fixed-case\">GLP\u20101R<\/jats:styled-content>\n                      ) agonist on metabolic variables in diet\u2010induced obese (\n                      <jats:styled-content style=\"fixed-case\">DIO<\/jats:styled-content>\n                      ) rodents.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A stabilized acetylated version of\n                      <jats:styled-content style=\"fixed-case\">CCK<\/jats:styled-content>\n                      \u20108 (Ac\u2010Y*\u2010\n                      <jats:styled-content style=\"fixed-case\">CCK<\/jats:styled-content>\n                      \u20108), selective\n                      <jats:styled-content style=\"fixed-case\">CCK1<\/jats:styled-content>\n                      receptor (\n                      <jats:styled-content style=\"fixed-case\">CCK1R<\/jats:styled-content>\n                      ) or\n                      <jats:styled-content style=\"fixed-case\">CCK2<\/jats:styled-content>\n                      receptor (\n                      <jats:styled-content style=\"fixed-case\">CCK2R<\/jats:styled-content>\n                      ) agonists, amylin or the\n                      <jats:styled-content style=\"fixed-case\">GLP\u20101R<\/jats:styled-content>\n                      agonist and exenatide analogue\n                      <jats:styled-content style=\"fixed-case\">AC3174<\/jats:styled-content>\n                      were administered in select combinations via continuous subcutaneous infusion to\n                      <jats:styled-content style=\"fixed-case\">DIO<\/jats:styled-content>\n                      rats for 14\u2009days, or\n                      <jats:italic>\n                        Lep\n                        <jats:sup>ob<\/jats:sup>\n                        \/Lep\n                        <jats:sup>ob<\/jats:sup>\n                      <\/jats:italic>\n                      mice for 28\u2009days, and metabolic variables were assessed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Combined administration of Ac\u2010Y*\u2010\n                      <jats:styled-content style=\"fixed-case\">CCK<\/jats:styled-content>\n                      \u20108 with either amylin or\n                      <jats:styled-content style=\"fixed-case\">AC3174<\/jats:styled-content>\n                      induced greater than additive weight loss in\n                      <jats:styled-content style=\"fixed-case\">DIO<\/jats:styled-content>\n                      rats, with the overall magnitude of effect being greater with\n                      <jats:styled-content style=\"fixed-case\">AC3174<\/jats:styled-content>\n                      \u2009+\u2009Ac\u2010Y*\u2010\n                      <jats:styled-content style=\"fixed-case\">CCK<\/jats:styled-content>\n                      \u20108 treatment. Co\u2010infusion of\n                      <jats:styled-content style=\"fixed-case\">AC3174<\/jats:styled-content>\n                      with a specific\n                      <jats:styled-content style=\"fixed-case\">CCK1R<\/jats:styled-content>\n                      agonist, but not a\n                      <jats:styled-content style=\"fixed-case\">CCK2R<\/jats:styled-content>\n                      agonist, recapitulated the weight loss mediated by\n                      <jats:styled-content style=\"fixed-case\">AC3174<\/jats:styled-content>\n                      \u2009+\u2009Ac\u2010Y*\u2010\n                      <jats:styled-content style=\"fixed-case\">CCK<\/jats:styled-content>\n                      \u20108 in\n                      <jats:styled-content style=\"fixed-case\">DIO<\/jats:styled-content>\n                      rats, suggesting that synergy is mediated by\n                      <jats:styled-content style=\"fixed-case\">CCK1R<\/jats:styled-content>\n                      activation. In a 4\u2009\u00d7\u20094 full\u2010factorial response surface methodology study in\n                      <jats:styled-content style=\"fixed-case\">DIO<\/jats:styled-content>\n                      rats, a synergistic interaction between\n                      <jats:styled-content style=\"fixed-case\">AC3174<\/jats:styled-content>\n                      and the\n                      <jats:styled-content style=\"fixed-case\">CCK1R<\/jats:styled-content>\n                      \u2010selective agonist on body weight and food intake was noted. Co\u2010administration of\n                      <jats:styled-content style=\"fixed-case\">AC3174<\/jats:styled-content>\n                      and the\n                      <jats:styled-content style=\"fixed-case\">CCK1R<\/jats:styled-content>\n                      \u2010selective agonist to obese diabetic\n                      <jats:italic>\n                        Lep\n                        <jats:sup>ob<\/jats:sup>\n                        \/Lep\n                        <jats:sup>ob<\/jats:sup>\n                      <\/jats:italic>\n                      mice elicited a significantly greater reduction in percentage of glycated haemoglobin and food intake relative to the sum effects of monotherapy groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      The anti\u2010obesity and antidiabetic potential of combined\n                      <jats:styled-content style=\"fixed-case\">GLP\u20101R<\/jats:styled-content>\n                      and\n                      <jats:styled-content style=\"fixed-case\">CCK1R<\/jats:styled-content>\n                      agonism is an approach that warrants further investigation.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/dom.12390","type":"journal-article","created":{"date-parts":[[2014,9,10]],"date-time":"2014-09-10T04:25:19Z","timestamp":1410323119000},"page":"61-73","source":"Crossref","is-referenced-by-count":57,"title":["Synergistic metabolic benefits of an exenatide analogue and\u00a0cholecystokinin in diet\u2010induced obese and leptin\u2010deficient rodents"],"prefix":"10.1111","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5356-6118","authenticated-orcid":false,"given":"J. L.","family":"Trevaskis","sequence":"first","affiliation":[{"name":"Amylin Pharmaceuticals, LLC  San Diego CA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Sun","sequence":"additional","affiliation":[{"name":"Amylin Pharmaceuticals, LLC  San Diego CA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Athanacio","sequence":"additional","affiliation":[{"name":"Amylin Pharmaceuticals, LLC  San Diego CA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"D'Souza","sequence":"additional","affiliation":[{"name":"Amylin Pharmaceuticals, LLC  San Diego CA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Samant","sequence":"additional","affiliation":[{"name":"Amylin Pharmaceuticals, LLC  San Diego CA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Tatarkiewicz","sequence":"additional","affiliation":[{"name":"Amylin Pharmaceuticals, LLC  San Diego CA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. S.","family":"Griffin","sequence":"additional","affiliation":[{"name":"Amylin Pharmaceuticals, LLC  San Diego CA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Wittmer","sequence":"additional","affiliation":[{"name":"Amylin Pharmaceuticals, LLC  San Diego CA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Wang","sequence":"additional","affiliation":[{"name":"Amylin Pharmaceuticals, LLC  San Diego CA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.\u2010H.","family":"Teng","sequence":"additional","affiliation":[{"name":"Amylin Pharmaceuticals, LLC  San Diego CA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Forood","sequence":"additional","affiliation":[{"name":"Amylin Pharmaceuticals, LLC  San Diego CA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. G.","family":"Parkes","sequence":"additional","affiliation":[{"name":"Amylin Pharmaceuticals, LLC  San Diego CA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. D.","family":"Roth","sequence":"additional","affiliation":[{"name":"Amylin Pharmaceuticals, LLC  San Diego CA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,10,14]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.00297.2007"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/oby.2011.50"},{"issue":"5","key":"e_1_2_7_4_1","first-page":"R776","article-title":"Cholecystokinin persistently suppresses meal size but not food intake in free\u2010feeding rats","volume":"246","author":"West DB","year":"1984","journal-title":"Am J Physiol"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/302703a0"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.2011.630660"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc08-0029"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/34.2.154"},{"issue":"6","key":"e_1_2_7_9_1","first-page":"R975","article-title":"Individual, but not simultaneous, glucagon and cholecystokinin infusions inhibit feeding in men","volume":"262","author":"Geary N","year":"1992","journal-title":"Am J Physiol"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.86.12.8107"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.clpt.6100272"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.19.10455"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.2000.278.4.R882"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-0115(00)00153-1"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0032967"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.physbeh.2010.02.023"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0031-9384(98)00110-3"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006676-199005000-00019"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.00732.2004"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.00599.2003"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.regpep.2006.12.021"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm00064a001"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/0304-4165(82)90274-4"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm990252e"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm00053a022"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(93)90126-E"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2014.02.040"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/wics.73"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00432156"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijo.0803284"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00014.2005"},{"key":"e_1_2_7_32_1","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1523\/JNEUROSCI.08-08-03018.1988","article-title":"Mechanisms of action of peripherally administered cholecystokinin octapeptide on brain stem neurons in the rat","volume":"8","author":"Raybould HE","year":"1988","journal-title":"J\u00a0Neurosci"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2005.05.008"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1210\/en.2010-0233"},{"issue":"4","key":"e_1_2_7_35_1","first-page":"R628","article-title":"Gastric and nongastric mechanisms for satiety action of cholecystokinin","volume":"254","author":"Moran TH","year":"1988","journal-title":"Am J Physiol"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-65-3-395"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0026-0495(96)90192-4"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-1062"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0026-0495(97)90117-7"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.00356.2011"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.7268408"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2003.08.036"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2011.02.001"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.1999.277.2.R582"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1038\/nn1214"},{"key":"e_1_2_7_46_1","doi-asserted-by":"publisher","DOI":"10.2337\/db11-0489"},{"key":"e_1_2_7_47_1","doi-asserted-by":"publisher","DOI":"10.2337\/db11-1109"},{"key":"e_1_2_7_48_1","doi-asserted-by":"publisher","DOI":"10.2337\/db13-1268"},{"key":"e_1_2_7_49_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12294"},{"key":"e_1_2_7_50_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00479.2010"},{"key":"e_1_2_7_51_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12040"},{"key":"e_1_2_7_52_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00182.2012"},{"key":"e_1_2_7_53_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0773.2002.910611.x"},{"key":"e_1_2_7_54_1","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp130301"},{"key":"e_1_2_7_55_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1992.71"},{"key":"e_1_2_7_56_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0706473105"},{"key":"e_1_2_7_57_1","doi-asserted-by":"publisher","DOI":"10.1038\/oby.2009.478"},{"key":"e_1_2_7_58_1","doi-asserted-by":"publisher","DOI":"10.1038\/oby.2008.461"},{"key":"e_1_2_7_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60205-5"},{"key":"e_1_2_7_60_1","doi-asserted-by":"publisher","DOI":"10.1210\/en.2013-1420"},{"key":"e_1_2_7_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2010.01.027"}],"container-title":["Diabetes, Obesity and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fdom.12390","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dom-pubs.pericles-prod.literatumonline.com\/doi\/pdf\/10.1111\/dom.12390","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:13:55Z","timestamp":1761862435000},"score":1,"resource":{"primary":{"URL":"https:\/\/dom-pubs.pericles-prod.literatumonline.com\/doi\/10.1111\/dom.12390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,14]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["10.1111\/dom.12390"],"URL":"https:\/\/doi.org\/10.1111\/dom.12390","archive":["Portico"],"relation":{},"ISSN":["1462-8902","1463-1326"],"issn-type":[{"value":"1462-8902","type":"print"},{"value":"1463-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,14]]}}}